Clinical Services > Pain management

New adaptive clinical trial for progressive MS

29 November, 2023

An adaptive clinical trial for Australians living with MS is hoping to reverse neurological damage caused by progressive multiple sclerosis.


Novel intervention to improve strength, mobility in rheumatoid arthritis

06 November, 2023

A novel exercise intervention being trialled by the University of South Australia researchers, in partnership with Arthritis SA, could help improve physical function and quality of life in people.


Nurses and clinicians key to reducing recreational cannabis harm

18 October, 2023

Supporting mental health nurses with information on the risks and benefits of recreational cannabis could help reduce harm caused by the substance.


In Conversation with a Trailblazer

17 October, 2023

Lauren Barber was recently recognised with the Health Minister's Award for Nursing Trailblazers for her contributions to the medical field with her ground-breaking medtech device. Here she shares her story as a part of our new feature on inspiring startup founders.


VR to help remove fear of needles

16 October, 2023

Breakthrough Victoria is investing in virtual reality technology to reduce patient pain, stress and anxiety when having blood tests, vaccinations and medical imaging.


Epilepsy drug reduces frequency of seizures, trial finds

11 October, 2023

A drug trialled for epilepsy patients is said to help reduce focal-onset seizures.


Ultrasound technique used for difficult venous access

15 August, 2023

Research into the use of ultrasound techniques to assist with intravenous cannula treatment has been implemented for Australian children.


Medigrowth, Deakin Uni partner for medicinal cannabis centre

12 July, 2023

Medigrowth, a fully licensed Australian medicinal cannabis biotech, has announced plans to build a Centre of Excellence in Geelong in partnership with Deakin University.


New drug targets the fundamental process of inflammation

10 July, 2023

A new class of anti-inflammatory medication developed in Australia is being prepared for regulatory approval.


New guidelines for safer opioid deprescribing

26 June, 2023

Eleven recommendations on when, how and in what situation it may be appropriate for clinicians to reduce opioid use by placing the patient at the centre of the equation have been released.


Headaches impact 75% of Australian women

23 May, 2023

A new survey suggests headaches affect 75% of women and 54% of men — and the impact could cost the Australian economy over $35.7 billion annually.


New chronic back pain trial reports significant improvements

08 May, 2023

A new treatment has helped long-term sufferers of chronic back pain experience significant reductions in pain and related disability.


Concern over paracetamol access for Australians in pain

17 March, 2023

Painaustralia has expressed disappointment at the TGA's interim decision to reduce the available pack sizes of paracetamol in Australia.


Study questions use of antidepressants for chronic pain

02 February, 2023

A review has found that while some antidepressants may be effective in treating certain chronic pain conditions, others are either not effective or the effectiveness is unknown.


Finding could pave way for new gut treatments

23 December, 2022

Chronic pain associated with gastrointestinal disorders could be treated by targeting the receptor responsible for sense of touch and temperature, new research reveals.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd